genetics

Casgevy is the first medicine licensed using the gene editing tool CRISPR. The approval could offer relief to thousands of people with the crippling illness in the U.K.

Many private and public health insurers won’t cover the $4,000-to-$8,000 expense of whole-genome sequencing. Florida now is among eight state Medicaid that programs do.

A recent study showed that tests for sick newborns that look at their full genetic blueprints are nearly twice as good at finding genetic problems as narrower, more commonly used tests.

Researchers are inching closer to creating human eggs and sperm in the lab that carry a full complement of anyone's DNA. It could revolutionize fertility treatment and raises huge ethical questions.

The experimental technique is an effort to prevent children from inheriting rare genetic diseases. Critics warn that tweaking the genetic code this way could be a slippery slope that leads to designer babies.

An Australian company has lifted the glass cloche on a meatball made of lab-grown cultured meat using the genetic sequence from the long-extinct mammoth. The high-tech treat isn't available to eat yet.

A Mississippi woman's life has been transformed by a treatment for sickle cell disease with the gene-editing technique CRISPR. All her symptoms from a disease once thought incurable have disappeared.

The first brain-delivered gene therapy on the market was recently approved in Europe and the U.K. for a rare genetic disorder called AADC deficiency. It causes developmental delays and movement disorders in kids.

Doctors are divided on whether blanket testing of breast cancer patients is warranted, since scientists and physicians are sometimes unsure about how to interpret the results.

Black and Hispanic people often don't volunteer for studies of Alzheimer's disease, despite their risks for developing it. Researchers are working to make studies more inclusive, but it's not easy.